Tuesday, July 29, 2025

Information Leakage in Clinical AI—Dr Julia Sidorova’s Hard Truths for Oncologists and Bioinformaticians

 

Are Your “High‑Accuracy” Models Built on Invisible Cracks?

Machine‑learning models that predict survival curves, tumor recurrence, or treatment response can look spectacular in a Jupyter notebook—right up until they meet real clinical data. The silent culprit? Information leakage: hidden shortcuts that slip illicit clues from the future or from duplicate patient records into the training set.

Dr Julia Sidorova (Research Scientist, Bioinformatics Platform, CIBER‑EHD, Spain) has made it her mission to reveal—and repair—those cracks. At Cancer 2025 she’ll dissect how leakage sneaks into pipelines, why it cripples external validation, and which safeguards every oncology data team should adopt.


What She’ll Cover on Stage

Leakage TypeReal‑World ExampleFix You’ll Learn
Temporal leakageFuture lab results “accidentally” present during trainingTime‑aware splits, forward‑chaining validation
Patient‑overlap leakageMultiple CT slices from the same patient split across foldsGrouped k‑fold, patient‑level indexing
Pretraining leakagePublic backbone pre‑exposed to pathology labelsAudit of pretraining datasets & feature ablation
Site/batch leakageModel learns the scanner brand, not the tumorComBat batch correction, domain adversarial nets

Key takeaway: When Dr Sidorova removed leakage, deep nets in survival analysis “often under‑performed vanilla linear regression.” Let that sink in.


Meet Dr Julia Sidorova

  • PhD, Universidad Pompeu Fabra (Barcelona)

  • Research Scientist, Instituto Carlos III de Salud (Madrid)

  • Editorial Board, Frontiers in Neurology (Biomarkers) & IJMS (SI: AI in Molecular Cancer)

  • 20+ peer‑reviewed papers merging classical stats with deep learning to test what really works


Event Snapshot

ConferenceInternational Conference on Cancer Science & Research (Cancer 2025)
Dates17 – 19 November 2025
FormatHybrid—Singapore onsite + fully interactive virtual platform



Why Attend?

  • Bulletproof your ML pipelines before they hit the clinic

  • Collect CPD credits and SCOPUS‑indexed proceedings

  • Network with oncologists, bioinformaticians, and AI regulators in one forum


Register Now

Secure your seat or virtual pass → https://cancer.miconferences.com/register

Questions?
📧 cancer@mathewsconference.com | ☎ +1 312 462 4448 | 💬 WhatsApp https://wa.me/14243770967


Let’s build AI models that earn clinicians’ trust—starting with a leak‑tight foundation.


#InformationLeakage #ClinicalAI #OncologyData #SurvivalAnalysis #Bioinformatics #MachineLearning #Cancer2025 #SingaporeEvents #CancerResearch #ModelValidation #DeepLearning #HealthcareAI #HybridConference #SingaporeEvents #OncologyConferences #CancerEvents

Wednesday, July 9, 2025

Nanomedicine’s Next Frontier: Prof. Thomas J. Webster Headlines Cancer 2025

About the Keynote Speaker
With an h-index of 129 and more than 70 000 citations, Prof. Thomas J. Webster has spent three decades converting nanotechnology concepts into FDA-approved products—most notably nano-structured spinal implants now enhancing the lives of 30 000+ patients without a single recorded failure. The former president of the U.S. Society for Biomaterials, founder of a dozen med-tech start-ups (several acquired by Medtronic), and recent Nobel Prize nominee, Prof. Webster currently serves on the faculty at Brown University, Hebei University of Technology, and other institutions worldwide.


Keynote Preview
Anti-Cancer Nanomedicine in Humans: 30 000 Successful Cases and Counting

Prof. Webster will trace his journey from lab bench to operating room, revealing how nano-engineered surfaces outperform conventional implants—especially for bone-cancer patients, where failure rates can reach 60 %. Expect to learn:

  • How nano topographies destroy cancer cells, bacteria and inflammation without drugs

  • FDA MAUDE data validating zero failures across tens of thousands of patients

  • The emerging era of 4D-printed, environmentally friendly, AI-guided nano-materials poised to slash healthcare costs and extend global life expectancy


Why This Session Matters

Conventional Challenge Nano-enabled Solution Prof. Webster Will Showcase
5 – 10 % implant failure (up to 60 % in bone cancer) Nano spinal implants with a perfect clinical track record
Rising drug resistance & cost Drug-free cancer killing via nano surface physics
Reactive, one-size-fits-all healthcare Predictive sensors and smart nano-materials tailored to each patient

Event Snapshot

Secure Your Seat
Lock in an onsite pass or virtual ticket now → https://cancer.miconferences.com/register

Contact Us
cancer@mathewsconference.com | ☎ +1 (312) 462-4448 | 💬 WhatsApp https://wa.me/14243770967


Join Prof. Webster and a global oncology community as we redefine cancer care through nanotechnology at Cancer 2025.


#Cancer2025 #Nanomedicine #Oncology #Biomaterials #NanoImplants #PrecisionMedicine #CPDCredits #CancerConferences #OncologyConferences #Anticancer

Cancer 2025: Group photo at Singapore

  🌟  Celebrating an Inspiring Gathering of Global Visionaries!  🌟 We are delighted to showcase this memorable group photo from the Interna...